U.S. Electronic Equipment and Components Stock News

Arbutus Biopharma FY 2025 Earnings Snapshot Arbutus Biopharma (ABUS) has turned in a mixed FY 2025 readout so far, with Q3 total revenue at US$0.5 million and a basic EPS loss of US$0.04, alongside trailing twelve month revenue of US$14.6 million and a basic EPS loss of US$0.22. Over recent quarters, the company has reported revenue in a range between US$0.5 million and US$10.7 million per quarter, while quarterly basic EPS has ranged from a loss of US$0.13 to a profit of US$0.01. This gives...

Jabil (NYSE:JBL) has committed $1.1 million over multiple years to support advanced manufacturing training at St. Petersburg College. The partnership will fund scholarships, upgrade manufacturing curriculum, and expand access to advanced technology for students in the Tampa Bay region. This initiative is aimed at developing a stronger local manufacturing talent pipeline and deepening Jabil's community engagement. For investors tracking NYSE:JBL, this move comes with the stock at a share...

Bally's (BALY) FY 2025 earnings snapshot Bally's (BALY) latest FY 2025 update centers on Q3 numbers, with revenue of US$663.7 million, a basic EPS loss of US$1.70, and net income loss of US$102.9 million as the company continues to operate in the red. Over recent quarters, revenue has ranged from US$580.4 million in Q4 2024 to US$663.7 million in Q3 2025, while quarterly basic EPS has moved between a loss of US$0.30 and a loss of US$5.10, underscoring pressure on profitability. For investors,...

Idaho Strategic Resources (IDR) has put up another solid set of numbers for FY 2025 so far, with third quarter revenue at about US$11.1 million, basic EPS of US$0.20 and trailing 12 month EPS of US$0.73 underpinning net income of US$10.27 million over the past year. The company has seen revenue step up from US$6.2 million in Q2 FY 2024 to US$7.6 million in Q4 FY 2024 and then to US$11.1 million in Q3 FY 2025. Quarterly basic EPS moved from US$0.17 to US$0.18 and now just over US$0.20, setting...

AEye (LIDR) has just joined the NVIDIA Halos AI Systems Inspection Lab while also releasing fourth quarter and full year 2025 results, a combination that puts both its technology partnerships and financial profile in focus. See our latest analysis for AEye. The share price has been volatile around these announcements, with a 7 day share price return of 44.52% and a 1 day decline of 13.51%. Over 1 year, the total shareholder return is very large compared to the longer term 3 year and 5 year...

Wondering if MDU Resources Group at around US$19.65 is offering value right now, or if the recent run puts it on the expensive side. The stock has pulled back about 4.7% over the past week and 2.9% over the past month, although the 1 year return sits at 18.7% and the 3 and 5 year returns are 91.5% and 89.5% respectively. Recent coverage has focused on MDU Resources Group as a regulated utility and infrastructure business. Investors are paying attention to how its mix of operations and...

Investors may be wondering if Astera Labs at around US$116 per share still offers value after a big run, or if they might be late to the story. The stock is up 63.2% over the last year, although the 7 day, 30 day and year to date returns of 3.5%, 10.5% and 35.4% declines show that enthusiasm has cooled recently. Recent coverage has focused on Astera Labs as a key player in semiconductor infrastructure and AI related hardware. This helps explain why the share price has attracted attention...

SS Innovations International, Inc. reported past 2025 results showing full-year revenue rising to US$42.48 million from US$20.65 million, while narrowing its net loss to US$12.13 million and disclosing auditor concerns about its ability to continue as a going concern. Separately, the company’s SSi Mantra surgical robotic system secured approval for telesurgeries in Indonesia and the Philippines and passed 150 cumulative telesurgeries, signaling expanding real-world use of its technology...

Recent stock performance and what it might signal Tyra Biosciences (TYRA) has drawn attention after a 2.7% decline in the last session, following a sharp move over the past 3 months that left the stock up 46.4%. Over the past month the shares are up 17.6%, while the 1 year total return stands at 247.5%, set against a recent closing price of US$37.15 and a market value of about US$2.0b. See our latest analysis for Tyra Biosciences. Put simply, Tyra Biosciences has combined sharp short term...

What the Emburse and DocuSign expansions mean for Dayforce stock Dayforce (DAY) has broadened its relationships with Emburse and DocuSign, folding expense management and digital agreement tools more tightly into its HCM platform through certified integrations and a reseller model. For you as an investor, this move centers on two practical ideas: Dayforce aiming to keep more of a customer’s HR workflow inside its own ecosystem, and partners gaining distribution through Dayforce’s channel. See...

Shareholders at Dominion Energy (NYSE:D) have filed several proposals ahead of the upcoming annual meeting focused on board independence and governance reforms. Key items include calls to separate the CEO and Chair roles, tie executive pay to ESG and DEI metrics, and expand mechanisms for shareholder engagement. The company has recommended that investors vote against these proposals, setting up a clear point of tension between management and some shareholder groups. Dominion Energy, a major...

Grupo Aeroméxico (NYSE:AERO) has filed a substantial shelf registration tied to an employee stock ownership plan. The registration relates to future issuance of shares to employees under the ESOP framework. The move signals a fresh phase in the company’s capital planning and workforce incentive approach. Grupo Aeroméxico, listed as NYSE:AERO, operates as Mexico’s flagship airline with a focus on passenger and cargo services. The new ESOP related shelf registration arrives at a time when...

If you are wondering whether Pharvaris at around US$26 a share still offers value, it helps to step back and look at what the recent returns and current valuation are really telling you. The stock has delivered a 68.8% return over the past year and a very large 3 year gain of around 3.5x, even though the year to date return is a 1.8% decline and the 30 day return is a 7.5% decline. This can change how the risk and reward balance feels right now. Recent headlines around Pharvaris have focused...

Coastal Financial (NasdaqGS:CCB) has appointed Jeffrey M. Chapman, a banking technology veteran with over 25 years of experience, to its Board of Directors. Chapman will serve on the Technology and CCBX Oversight Committees, with the appointment highlighting a focus on digital banking and platform development. Coastal Financial, trading at $74.36, has seen a mixed share price record, with a 103.6% return over 3 years and a 176.9% return over 5 years, alongside a 34.4% decline year to date...

Clear Channel Outdoor’s Airports Division recently secured a new 10‑year contract with the Omaha Airport Authority to continue providing advertising at Omaha Eppley Airfield, backed by a US$1,000,000 investment in a modern, integrated media program targeting more than 5.2 million annual passengers. The contract highlights how upgraded digital displays, sponsorships, and local business partnerships could deepen Clear Channel Outdoor’s presence in airport advertising and support its broader...

SWK Holdings (SWKH) closed out FY 2025 with fourth quarter revenue of US$6.6 million and a basic EPS loss of US$1.60, compared with revenue of US$9.2 million and basic EPS of US$0.48 in the same quarter a year earlier. The trailing twelve month EPS came in at a loss of US$0.21 on revenue of US$37.6 million. Over recent quarters, revenue has moved from US$9.2 million in Q4 2024 to US$12.2 million in Q1 2025, US$8.1 million in Q2 2025 and US$10.6 million in Q3 2025. Basic EPS shifted from...

Wondering whether GeneDx Holdings at around US$69.84 is a bargain or already pricing in a lot of optimism? This article walks through what the numbers currently say about value. The stock has had a choppy run, with a 10.2% decline over the last 7 days, a 14.9% decline over the last 30 days, a 47.2% decline year to date, a very large 3 year return, and a 33.1% decline over the last year. These swings have kept GeneDx on the radar for investors watching for changing expectations and risk...

Opera (NasdaqGS:OPRA) and Celo have agreed a restructured, multi year partnership that makes Opera a major network stakeholder in the Celo ecosystem. The deal centers on MiniPay and a planned push to drive global stablecoin usage across up to 50 million Opera users. The partnership includes a 160 million CELO allocation, expansion of MiniPay into new markets, and grassroots roadshows to support user adoption. Opera, trading at $14.36, now ties a bigger part of its fintech plans to the Celo...

Wondering if Hess Midstream at around US$39.59 is still offering value, or if most of the easy gains are already on the table. The stock has returned 1.5% over the last 7 days, 4.5% over the last 30 days, 14.3% year to date and 0.4% over the past year, with very large returns over the past 3 and 5 years of 85.1% and 173.4% respectively. Recent coverage has focused on Hess Midstream's role as a midstream infrastructure provider and how that positions the company within the broader energy...

Wondering if Innospec, at around its recent US$65.89 close, is offering value or a value trap? This review breaks down what the current share price really reflects. The stock has recently seen a 4% decline over the past week, an 18.9% decline over the past month, and a 29.9% decline over the last year, which may signal that the market is reassessing both growth potential and risk. Recent coverage of Innospec has focused on its position within the chemicals sector and how investors are...

TransUnion (NYSE:TRU) has rolled out new machine learning capabilities within its Device Risk fraud prevention solution. The update targets recent surges in digital fraud and suspected account takeovers, aiming to improve detection accuracy and reduce manual review work for clients. The company is highlighting adaptive, consortium driven risk scoring as a way to respond to more complex fraud patterns in digital channels. TransUnion enters this product update phase with its shares at $70.55...

In March 2026, AEye, Inc. announced it had joined the ANAB-accredited NVIDIA Halos AI Systems Inspection Lab to collaborate on validating safety, cybersecurity, and system integration of its Apollo, STRATOS, and OPTIS lidar solutions with NVIDIA DRIVE platforms. On the same day, AEye reported fourth-quarter 2025 sales of US$97,000 and a net loss of US$7.34 million, with full-year 2025 sales of US$233,000 and a net loss of US$33.96 million, showing modest revenue progress alongside continued...

TG Therapeutics, ticker NasdaqCM:TGTX, announced a new five year, $750 million senior secured credit facility with Blue Owl Capital. The agreement is described as non dilutive, meaning it does not involve issuing new equity to raise capital. The facility includes repayment of prior debt and could expand to as much as $1b in total available financing. TG Therapeutics focuses on developing and commercializing therapies in the biopharmaceutical space, where access to sizeable, flexible capital...

Investors may be wondering whether Progress Software's current share price reflects its true value, or if the recent weakness is opening up an opportunity. The stock closed at US$31.29, with returns of an 8.8% decline over 7 days, a 22.4% decline over 30 days, a 23.8% decline year to date, and a 42.5% decline over 1 year. These moves may have shifted how the market views its risk and reward trade off. Recent headlines have focused on Progress Software's role as a software provider and how...